Our team is actively engaged in clinical research that aims to help professionals and families understand more about the 22q deletion and its impact on affected children. Through such investigative efforts, we will learn how best to care for our patients and how to best help them live healthy and productive lives.
To see current research studies related to 22q Deletion Syndrome being conducted at Nationwide Children's Hospital, search the options below.
Researchers at Nationwide Children’s Hospital are looking for infants and toddlers (ages 8-36 months) with 22q11.2 deletion syndrome (also known as DiGeorge or Velocardiofacial syndrome) to participate in a new study of speech development. We will be recording children’s speech with a small, portable recording device that fits in a special vest that the child wears at home while they speak. The speech recording will allow us to learn about how much children speak at home, the sounds they make, and what sounds they hear in their environment.
For more information about this study, contact Adriane Baylis, PhD, CCC-SLP at (614) 722-3895 or Adriane.Baylis@NationwideChildrens.org.